GRM5 and temporal lobe epilepsy: To our knowledge, the only study testing mGluR5 drugs in a virus model was in a virus-induced temporal lobe epilepsy (TMEV) model where treatment with the PAM VU0360172 reduced acute seizures, while blocking mGluR5 did not make seizure phenotypes worse (Hanak et al., 2019).